Results 11 to 20 of about 18,611 (183)

Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis

open access: goldBlood Advances, 2023
Key Points • MAPK alterations are a hallmark of ECD and RDD.• The MEK inhibitor trametinib is active in non-LCHs, including those without BRAF V600E mutations.
Ashley Aaroe   +12 more
openalex   +2 more sources

Non‐Langerhans cell histiocytosis xanthogranuloma patient with varying histopathology leading to progressive nodular histiocytosis

open access: greenJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2021
Subclassifying non-Langerhans cell histiocytosis (non-LCH) had been controversial for several decades. Zelger et al. suggested the concept of classifying non-LCH according to the morphology of predominant histiocytes [1].
Yeongjoo Oh, Jemin Kim, Chang Ook Park
openalex   +3 more sources

Isolated Bone Marrow Non–Langerhans Cell Histiocytosis Preceding RUNX1-Mutated Acute Myeloid Leukemia: Case Report and Literature Review [PDF]

open access: bronzeAmerican Journal of Clinical Pathology, 2019
OBJECTIVES The prevalence of concomitant myeloid neoplasms was recently reported to be unexpectedly high among adults without non-Langerhans cell histiocytosis (non-LCH); however, the coexistence of non-LCH with RUNX1 genetic aberration has not been ...
Areej Al Mugairi   +5 more
openalex   +2 more sources

Non Langerhans Cell Histiocytosis of the Rectum: Case Report and Review of the Literature

open access: diamondJapanese Journal of Gastroenterology and Hepatology, 2022
Histiocytosis is a condition resulting from the abnormal proliferation of dentritic cells of the mononuclear phagocytic system. Previously classified as Langerhans cell histiocytosis and non-Langerhans cell histiocytosis, and recently into 5 categories ...
Malek Michael Bouhairie   +3 more
openalex   +2 more sources

A rare cutaneous lesion in the neonatal period: The non-Langerhans cell histiocytosis

open access: diamondMarmara Medical Journal, 2020
The non-Langerhans cell histiocytosis (non-LCH) is a group of diseases characterized by cutaneous involvement in the neonatal period. The non-LCH affects less than 1 in 200,000 children born each year.
Adnan Barutçu   +3 more
openalex   +3 more sources

Novel actionable ROS1::GIT2 fusion in non-Langerhans cell histiocytosis with central nervous system involvement. [PDF]

open access: hybridActa Neuropathol, 2023
Bedics G   +9 more
europepmc   +3 more sources

Renovascular Hypertension: Unraveling a Case of Mixed Histiocytosis

open access: yesAnnals of Internal Medicine: Clinical Cases, 2023
Renovascular hypertension is a cause of secondary hypertension. Atherosclerotic renal artery stenosis and fibromuscular dysplasia are the main causes, but other rare entities can involve the renal arteries.
Pedro Marques   +8 more
doaj   +1 more source

Adult-onset of Langerhans cell histiocytosis: a clinical case

open access: yesAlʹmanah Kliničeskoj Mediciny, 2021
Langerhans cell histiocytosis is mainly diagnosed in children, and its manifestation in adult age is quite uncommon. Skin rashes may be non-specific and mimic a number of dermatoses.
Olga V. Chernysheva   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy